Exhaled breath condensate biomarkers reflect systemic changes in patients with chronic dioxin intoxication
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10379652" target="_blank" >RIV/00216208:11110/18:10379652 - isvavai.cz</a>
Alternative codes found
RIV/61388955:_____/18:00493462 RIV/00064165:_____/18:10379652
Result on the web
<a href="https://doi.org/10.1007/s00706-018-2211-1" target="_blank" >https://doi.org/10.1007/s00706-018-2211-1</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00706-018-2211-1" target="_blank" >10.1007/s00706-018-2211-1</a>
Alternative languages
Result language
angličtina
Original language name
Exhaled breath condensate biomarkers reflect systemic changes in patients with chronic dioxin intoxication
Original language description
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is highly toxic and affects the cardiovascular system, brain, and skin by AhR-dependent and other mechanisms, as well as causing metabolic impairments and cancer. The involvement of the respiratory system has not yet been studied. TCDD in the blood was measured and biomarkers of oxidative stress and inflammation were analysed in 2016 in the exhaled breath condensate (EBC) of the last eight male survivors (mean age 72.4 +/- 1.3 years) from 80 workers intoxicated with TCDD during the production of herbicides from 1965 to 1968. The results were compared with their findings in 2010 to evaluate a trend. Malondialdehyde, 4-hydroxy-trans-nonenale, and 8-isoprostaglandin F2 alpha (8-isoprostane), in addition to markers of the oxidation of nucleic acids and proteins 8-hydroxy-2-deoxyguanosine, 8-hydroxyguanosine, 5-(hydroxymethyl)uracil, o-tyrosine, and 3-nitrotyrosine, as well as markers of inflammation leukotrienes and anti-inflammatory lipoxins, were analysed in EBC by liquid chromatography-electrospray ionisation-tandem mass spectrometry. In addition, the patients underwent chest X-ray, spirometry and fractional exhaled nitric oxide (FeNO) examinations. The control group included 7 men (66 +/- 16 years) with comparable lifestyle factors. The median plasma TCDD level lowered from 155 (28-553) ng/kg fat in 2010 to 112 (46-390) ng/kg fat in 2016, i.e., 50 years after exposure. The mean TCDD body deposit was 5.0 +/- 3.7 A mu g. Serum TCDD level in the pooled sample of the controls was 12 ng/kg fat. All markers of oxidative stress, LTB4 and LTC4, remained overexpressed in patients and anti-inflammatory lipoxins were under-expressed compared to controls (all p < 0.01). The mean FeNO and spirometry results were within the reference values. Borderline X-ray findings and combined lung function impairments were seen in the patients with the lower TCDD plasma levels. Differences in the expression of the biomolecular markers in EBC as compared to controls were not associated with lung impairments and the respiratory parameters measured. Therefore, these EBC markers can be used to evaluate systemic oxidative stress and inflammation in tissues and the endovascular, atherosclerotic, neurotoxic, and metabolic effects of TCDD. [GRAPHICS] .
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30108 - Toxicology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Monatshefte für Chemie - Chemical Monthly
ISSN
0026-9247
e-ISSN
—
Volume of the periodical
149
Issue of the periodical within the volume
9
Country of publishing house
AT - AUSTRIA
Number of pages
8
Pages from-to
1579-1586
UT code for WoS article
000442501400013
EID of the result in the Scopus database
2-s2.0-85052139033